MYRIAD GENETICS INC Insider Trading for April 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MYRIAD GENETICS INC for April 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 18.06 | 31,516 | 569,179 | 0 | |
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 39.80 | 31,516 | 1,254,337 | 18,285 | 49.8 K to 18.3 K (-63.28 %) |
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 18.06 | 31,516 | 569,179 | 49,801 | 18.3 K to 49.8 K (+172.36 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 18.06 | 28,484 | 514,421 | 31,516 | |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 39.80 | 28,484 | 1,133,663 | 18,285 | 46.8 K to 18.3 K (-60.90 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 18.06 | 28,484 | 514,421 | 46,769 | 18.3 K to 46.8 K (+155.78 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 3,208 | 0 | 18,285 | 21.5 K to 18.3 K (-14.93 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 27.07 | 17,500 | 473,725 | 51,907 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 21,966 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 23.98 | 3,500 | 83,930 | 7,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 28,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 8,034 | 199,966 | 8,034 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 8,034 | 328,566 | 930 | 9 K to 930 (-89.63 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 8,034 | 199,966 | 8,964 | 930 to 9 K (+863.87 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 21,966 | 898,344 | 930 | 22.9 K to 930 (-95.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 21,966 | 546,734 | 22,896 | 930 to 22.9 K (+2,361.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 28,000 | 1,145,116 | 930 | 28.9 K to 930 (-96.79 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 19.47 | 28,000 | 545,160 | 28,930 | 930 to 28.9 K (+3,010.75 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 3,500 | 143,140 | 930 | 4.4 K to 930 (-79.01 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 23.98 | 3,500 | 83,930 | 4,430 | 930 to 4.4 K (+376.34 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 17,500 | 715,698 | 930 | 18.4 K to 930 (-94.95 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 27.07 | 17,500 | 473,725 | 18,430 | 930 to 18.4 K (+1,881.72 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 76,139 | 2,310,057 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 3,861 | 117,143 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 3,861 | 154,440 | 47,609 | 51.5 K to 47.6 K (-7.50 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 3,861 | 117,143 | 51,470 | 47.6 K to 51.5 K (+8.11 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 76,139 | 3,045,560 | 47,609 | 123.7 K to 47.6 K (-61.53 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 76,139 | 2,310,057 | 123,748 | 47.6 K to 123.7 K (+159.93 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 18.06 | 30,000 | 541,800 | 30,000 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 54,676 | 726,097 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 54,676 | 2,167,701 | 14,551 | 69.2 K to 14.6 K (-78.98 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 54,676 | 726,097 | 69,227 | 14.6 K to 69.2 K (+375.75 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 5,324 | 211,077 | 14,551 | 19.9 K to 14.6 K (-26.79 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 5,324 | 70,703 | 19,875 | 14.6 K to 19.9 K (+36.59 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.80 | 30,000 | 1,194,066 | 14,551 | 44.6 K to 14.6 K (-67.34 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 18.06 | 30,000 | 541,800 | 44,551 | 14.6 K to 44.6 K (+206.17 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 3,000 | 118,939 | 14,551 | 17.6 K to 14.6 K (-17.09 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 30.12 | 55,000 | 1,656,600 | 52,654 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 39.57 | 55,000 | 2,176,350 | 15,084 | 70.1 K to 15.1 K (-78.48 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 30.12 | 55,000 | 1,656,600 | 70,084 | 15.1 K to 70.1 K (+364.62 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 11,000 | 0 | 15,084 | 26.1 K to 15.1 K (-42.17 %) |